相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of tuna protein-derived peptides as potent SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
Zhipeng Yu et al.
FOOD CHEMISTRY (2021)
Identification of novel umami peptides from myosin via homology modeling and molecular docking
Zhipeng Yu et al.
FOOD CHEMISTRY (2021)
Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1-mediated mitochondrial dysfunction
Xiaodong Zhuang et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
MicroRNA-98 ameliorates doxorubicin-induced cardiotoxicity via regulating caspase-8 dependent Fas/RIP3 pathway
Yang Pan et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2021)
Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors
Zhipeng Yu et al.
FOOD & FUNCTION (2020)
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Mei Songbo et al.
TOXICOLOGY LETTERS (2019)
Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin
Wei Shi et al.
MOLECULES (2018)
A Polysaccharide Purified from Morchella conica Pers. Prevents Oxidative Stress Induced by H2O2 in Human Embryonic Kidney (HEK) 293T Cells
Na Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction
Xin-Qiao Tian et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Paweorn Angsutararux et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
Jing Sun et al.
PLOS ONE (2013)
Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats
Rehan Khan et al.
BRITISH JOURNAL OF NUTRITION (2012)
Anthracycline cardiotoxicity
Pierantonio Menna et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer Current Evidence and Underlying Mechanisms
Jessica M. Scott et al.
CIRCULATION (2011)
Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: Potential role of tannins in cancer chemotherapy
Kulbhushan Tikoo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
Douglas B. Sawyer et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Control of mitochondrial apoptosis by the Bcl-2 family
Joslyn K. Brunelle et al.
JOURNAL OF CELL SCIENCE (2009)
Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
Masashi Yoshida et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy
Nihat Kalay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes
Peter H. Sugden et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Free radical biology and medicine: it's a gas, man!
William A. Pryor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
L Wojnowski et al.
CIRCULATION (2005)
The transcriptional targets of p53 in apoptosis control
J Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
B Kalyanaraman et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis
M Crompton
CURRENT OPINION IN CELL BIOLOGY (2000)
Cardiotoxicity of doxorubicin and other anthracycline derivatives
D Jain
JOURNAL OF NUCLEAR CARDIOLOGY (2000)
分享论文
